🔗 Share this article

An underground market for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.

Experimental Drug Gaining Traction Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are urged to message these profiles privately for supplier links, while also receiving promotional offers.

Active Commerce on Social Networks

Separately, a flourishing market exists on messaging services, where communities with numerous of participants share “before and after” photos, injection guides and assertions of rapid British shipping. Sellers market the drug there before directing buyers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Professionals Voice Concerns

Nevertheless, physicians and pharmacists have warned that the sale of what remains an unlicensed drug in the UK is a cause for concern and could result in individuals administering products of uncertain source.

Several experts stated the popularity for the experimental drug could be linked to the increasing price of licensed slimming products such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some content creators attempt to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach medicines, marketing, and customer regulations, risking penalties, legal action or imprisonment.

Platform Response and Content Elimination

According to TikTok, the service has removed problematic content and banned related hashtags and search suggestions. The organization said it was committed to keeping the platform secure and allocating resources in enhancing compliance measures.

Online Trading Activities

Research also found communities with up to nine thousand members selling the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately displays groups with numerous of users, filled with images of slimming results, glowing reviews and step-by-step instructions for preparing or injecting at home.

After minutes of entering one group, a seller shared WhatsApp details, where most transactions take place. The seller provided an guidebook and guaranteed shipping within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. None asked about body mass, health issues or previous experience.

Item Details and Pricing

Inside these groups, messages show dark colored parcels with Royal Mail labels, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with purified liquid, or pre-filled pens typically priced at 160 pounds for 20 milligrams. When asked how long a pen should last, sellers give contradictory responses ranging from a several days to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for the messaging service said it actively monitored harmful content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are administering substances they cannot confirm. Although the research behind retatrutide is valid, these digital versions may not include what they claim,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were made in was clean,” she said.

Her staff has already encountered individuals harmed by self-injection from unverified suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly investigational substance not yet approved … may subject users to possibly significant medical dangers”.